Cabot Corp (CBT) director Christine Yan reports 2,298-share equity grant

Rhea-AI Filing Summary

Cabot Corporation director Christine Y. Yan reported receiving 2,298 shares of Cabot common stock on January 8, 2026, as an acquisition transaction. The shares were credited at a price of $0.00 per share under Cabot's Non-Employee Directors' Deferral Plan, meaning they represent deferred director compensation rather than an open-market purchase. Following this transaction, Yan beneficially owned 17,171 shares of Cabot common stock in direct form. This filing reflects routine equity-based compensation for a non-employee director rather than a cash trade in the stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yan Christine Y

(Last) (First) (Middle)

C/O CABOT CORPORATION

TWO SEAPORT LANE, SUITE 1400

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CABOT CORP [ CBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/08/2026		A		2,298(1)	A	$0	17,171	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.

	By: Jennifer Lombardi, pursuant to a power of attorney from Christine Y. Yan	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cabot Corp (CBT) report for Christine Y. Yan?

Cabot Corp director Christine Y. Yan reported an acquisition of 2,298 shares of Cabot common stock on January 8, 2026, coded as transaction type "A" (acquired).

At what price were the Cabot Corp (CBT) shares acquired by Christine Y. Yan?

The 2,298 Cabot common shares reported by Christine Y. Yan were acquired at a stated price of $0.00 per share, consistent with shares credited under a compensation or deferral arrangement rather than a market purchase.

How many Cabot Corp (CBT) shares does Christine Y. Yan own after this Form 4 transaction?

After the reported transaction, Christine Y. Yan beneficially owned 17,171 shares of Cabot common stock, held in direct ownership form according to the filing.

What plan governs the shares reported in this Cabot Corp (CBT) Form 4?

The filing explains that the reported shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan, indicating they arise from a director compensation deferral program.

Is Christine Y. Yan a director or officer of Cabot Corp (CBT)?

Yes. The Form 4 identifies Christine Y. Yan as a director of Cabot Corp and indicates she is not reported as an officer or 10% owner in this filing.

Does this Cabot Corp (CBT) Form 4 involve derivative securities or only common stock?

The reported transaction involves Cabot common stock as a non-derivative security. The section for derivative securities is present but contains no reported derivative transactions in this excerpt.